Item Type | Name |
Concept
|
Survival Rate
|
Concept
|
Cell Survival
|
Concept
|
Disease-Free Survival
|
Concept
|
Survival Analysis
|
Concept
|
Graft Survival
|
Academic Article
|
Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: are we changing life expectancy?
|
Academic Article
|
Preoperative Tracheostomy Is Associated with Poor Disease-Free Survival in Recurrent Laryngeal Cancer.
|
Academic Article
|
Pretreatment serum xanthophyll concentrations as predictors of head and neck cancer recurrence and survival.
|
Academic Article
|
Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.
|
Academic Article
|
Aspirin use and head and neck cancer survival and recurrence.
|
Academic Article
|
Squamous cell carcinoma subverts adjacent histologically normal epithelium to promote lateral invasion.
|
Academic Article
|
Oropharyngoplasty with template-based reconstruction of oropharynx defects.
|
Academic Article
|
Histologic pattern of invasion and epithelial-mesenchymal phenotype predict prognosis in squamous carcinoma of the head and neck.
|
Academic Article
|
Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population.
|
Academic Article
|
Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?
|
Academic Article
|
Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynx.
|
Academic Article
|
Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.
|
Academic Article
|
Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
|
Academic Article
|
Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
|
Academic Article
|
Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma.
|
Academic Article
|
Nuclear factor-kappaB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma.
|
Academic Article
|
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.
|
Academic Article
|
Classification of TP53 mutations and HPV predict survival in advanced larynx cancer.
|
Academic Article
|
Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx.
|
Academic Article
|
Integrating surgery into treatment paradigms for organ preservation: tailoring treatment to biology improves outcomes.
|
Academic Article
|
Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma.
|
Academic Article
|
Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer.
|
Academic Article
|
Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.
|
Academic Article
|
Family history of cancer and head and neck cancer survival.
|
Academic Article
|
Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancer.
|
Academic Article
|
Biomarkers in advanced larynx cancer.
|
Academic Article
|
Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
|
Academic Article
|
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
|
Academic Article
|
Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients.
|
Academic Article
|
Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma.
|
Academic Article
|
Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329.
|
Academic Article
|
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
|
Academic Article
|
Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma.
|
Academic Article
|
Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.
|
Academic Article
|
Reexamining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited.
|
Academic Article
|
Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristics.
|
Academic Article
|
Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy.
|
Academic Article
|
Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.
|
Academic Article
|
Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.
|
Academic Article
|
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
|
Academic Article
|
Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.
|
Academic Article
|
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.
|
Academic Article
|
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.
|
Academic Article
|
Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.
|
Academic Article
|
Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
|
Academic Article
|
Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.
|
Academic Article
|
Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples.
|
Academic Article
|
Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.
|
Academic Article
|
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking.
|
Academic Article
|
Capecitabine after Surgical Salvage in Recurrent Squamous Cell Carcinoma of Head and Neck.
|
Academic Article
|
Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapy.
|
Academic Article
|
HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
|
Academic Article
|
Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer.
|
Academic Article
|
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion.
|
Academic Article
|
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.
|
Academic Article
|
Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer.
|
Academic Article
|
Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
|
Academic Article
|
Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis.
|